chr2-222297157-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_181458.4(PAX3):c.142G>A(p.Gly48Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G48C) has been classified as Pathogenic.
Frequency
Consequence
NM_181458.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX3 | NM_181458.4 | c.142G>A | p.Gly48Ser | missense_variant | 2/9 | ENST00000392070.7 | NP_852123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAX3 | ENST00000392070.7 | c.142G>A | p.Gly48Ser | missense_variant | 2/9 | 1 | NM_181458.4 | ENSP00000375922 | A1 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 35
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 25, 2023 | Variant summary: PAX3 c.142G>A (p.Gly48Ser) results in a non-conservative amino acid change located in the Paired domain (IPR001523) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 228472 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. Other missense variants in the same residue (p.Gly48Arg and p.Gly48Cys) have been associated with pathogenicity in ClinVar, however the evidence for this variant is insufficient to determine a role in disease. To our knowledge, no occurrence of c.142G>A in individuals affected with Waardenburg Syndrome Type 1 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at